The distribution of COVID-19 vaccines like Moderna, Pfizer, and others demands immediate supply chain analysis and preparation.
Success awaits innovators that leverage pharma in a newly digitized world.
Software-only products providing free-standing treatment represent a key healthcare opportunity for incumbents.
Three CEOs discuss why digital treatments are on the cusp of becoming mainstream and share their five-year outlooks.
Five workstreams to help leaders adopt a new organizational approach.
It's time to get comfortable with being uncomfortable.
Innovator-Led Innovations May Soon Come True
Healthcare leaders demand disruption, but who will spark big change first?
A closer look at how fast change may happen, who could win (and lose), and how the next decade may unfold for incumbents and new market entrants.
Seeing a return on investment in pharma marketing means understanding what happens to every dollar.
Those challengers who address critical patient needs beyond traditional treatment will become a force to be reckoned with.